+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cholesterol trapping in Niemann-Pick disease type B fibroblasts can be relieved by expressing the phosphotyrosine binding domain of GULP



Cholesterol trapping in Niemann-Pick disease type B fibroblasts can be relieved by expressing the phosphotyrosine binding domain of GULP



Journal of Clinical Lipidology 7(2): 153-164



Impairment of acid sphingomyelinase (SMase) results in accumulation of sphingomyelin (SM) and cholesterol in late endosomes, the hallmarks of a lysosomal storage disease. We describe cellular lipid metabolism in fibroblasts from two patients with novel compound heterozygote mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene manifesting as Niemann-Pick disease type B (NPB) and demonstrate mechanisms to overcome the storage defect. Using biochemical assays and confocal microscopy, we provide evidence that accumulated lysosomal SM and cholesterol can be released by different treatments. Defective SMase activity in these fibroblasts results in a 2.5-fold increased cellular mass of SM and cholesterol, increased de novo endogenous cholesterol synthesis, and decreased cholesterol esterification, demonstrating impaired intracellular cholesterol homeostasis. Depletion of exogenous addition of cholesterol for 24 hours or addition of the cholesterol acceptor apolipoprotein A-I are sufficient to restore normal homeostatic responses. In an effort to correct the lysosomal storage phenotype of NPB, we infected the fibroblasts with a lentivirus expressing the phosphotyrosine binding domain of the adapter protein GULP (PTB-GULP). We have previously shown that expression of PTB-GULP in Chinese hamster ovary cells promotes intracellular cholesterol trafficking and ABCA1-mediated cholesterol efflux. We find that expression of PTB-GULP in NPB fibroblasts results in increased ABCA1 expression, increased cellular cholesterol efflux and lysosomal cholesterol redistribution, independent of the impaired SMase and cholesterol presence. We provide extensive functional characterization of a novel compound heterozygote mutation and provide a novel functional mechanism to overcome lysosomal storage disease defects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036768291

Download citation: RISBibTeXText

PMID: 23415435

DOI: 10.1016/j.jacl.2012.02.006


Related references

Alterations in cholesterol metabolism in cultured fibroblasts from patients with Niemann-Pick disease type C. Journal of Inherited Metabolic Disease 10(4): 339-346, 1987

Cultured fibroblasts from patients with Niemann-Pick disease type C and type D exhibit distinct defects in cholesterol esterification. Biochimica et Biophysica Acta 1124(1): 29-35, 1992

Cultured fibroblasts from patients with niemann pick disease type c and type d exhibit distinct defects in regulation of cholesterol metabolism. FASEB Journal 4(7): A1745, 1990

A study on intracellular cholesterol metabolism in cultured skin fibroblasts of Niemann-Pick disease type C. Sapporo Medical Journal 62(2): 113-122, 1993

Changes in the biosynthesis, esterification and efflux of cholesterol in fibroblasts in culture from patients with Niemann-Pick disease type C. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 180(6): 669-676, 1986

Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proceedings of the National Academy of Sciences of the United States of America 108(47): 18932-6, 2012

A mouse model of niemann pick disease i abnormalities in cholesterol metabolism in the 3t3 cell line are similar to those in cells from niemann pick disease type c and i cell disease. American Journal of Human Genetics 49(4 SUPPL): 154, 1991

Type C Niemann-Pick disease: dimethyl sulfoxide moderates abnormal LDL-cholesterol processing in mutant fibroblasts. Biochimica et Biophysica Acta 1006(2): 219-226, 1989

Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proceedings of the National Academy of Sciences of the United States of America 100(5): 2512-2517, 2003

Effect of a peroxysomal proliferator agent on intracellular cholesterol accumulation in cultured fibroblasts from Niemann-Pick type C disease patients. Clinica Chimica Acta 336(1-2): 137-142, 2003

Co-cultivation of Niemann-Pick disease type C fibroblasts belonging to complementation groups alpha and beta stimulates LDL-derived cholesterol esterification. Journal of Inherited Metabolic Disease 19(6): 769-774, 1996

Niemann-Pick type C disease: a QM/MM study of conformational changes in cholesterol in the NPC1(NTD) and NPC2 binding pockets. Biochemistry 53(41): 6603-6614, 2015

Type C Niemann-Pick disease. A parallel loss of regulatory responses in both the uptake and esterification of low density lipoprotein-derived cholesterol in cultured fibroblasts. Journal of Biological Chemistry 261(35): 16775-16780, 1986

Intracellular transport of cholesterol in type C Niemann-Pick fibroblasts. Biochimica et Biophysica Acta 1005(3): 303-309, 1989

Defective activity of acyl-CoA:cholesterol O-acyltransferase in Niemann-Pick type C and type D fibroblasts. Biochemical Journal 262(3): 713-719, 1989